ArticleBMJ open2021

Phase 3 randomised trial of eltrombopag versus standard first-line pharmacological management for newly diagnosed immune thrombocytopaenia (ITP) in children: study protocol.

Kristin A Shimano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.